STIs
Conference Coverage
Meningococcal vaccine shows benefit in STI prevention
“The duration of protective efficacy – a big thing in vaccines – is unknown. Still, this is really significant.”
Feature
‘Infuriating’ prescription denial leaves patient without antiemetics
The patient was experiencing severe side effects from standard chemoradiation with weekly cisplatin.
Latest News
USPSTF recommends against routine herpes screening for asymptomatic teens and adults
The updated recommendation confirms that harms outweigh benefits for population-based genital HSV screening.
From the Journals
Scientists create ‘vagina on a chip’: What to know
Researchers see the chip as a way to facilitate vaginal health research and open the door to vital new treatments.
Feature
Highly anticipated HIV vaccine fails in large trial
The vaccine had been in development since 2019 and was given to 3,900 study participants through October 2022.
Conference Coverage
Meningococcal B vaccine protects against gonorrhea
A complete vaccination series (two MenB-4C doses) was 40% effective.
Latest News
A new use for dating apps: Chasing STDs
With people migrating online to meet partners, following them there makes sense.
Latest News
More work needed to optimize STI screening in primary care settings
Primary care doctors should incorporate some questions about sexual health during a regular head-to-toe checkup and ask questions in a very...
From the Journals
Opt-out HIV testing in EDs can help identify undiagnosed cases
On implementation of opt-out testing, the proportion of tests performed increased from 57.9% to 69% in a study.
Latest News
As STDs proliferate, companies rush to market at-home test kits. But are they reliable?
The FDA wants companies to prove that home collection kits are as accurate as those used in clinics, and that samples don’t degrade during...
Latest News
Genital HSV shedding declines rapidly in first year post infection
Most genital shedding in first year after infection was asymptomatic, with few oral and genital lesions.